The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: A long-term follow-up study

British Journal of Haematology

Volumn 98, Issue 2, 1997, Pages 375-383

  Matutes, E ^a   Meeus, P ^a   Mclennan, K ^a   Catovsky, D ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Deoxycoformycin; Hairy cell; Immunohistochemistry; Minimal residual disease

Indexed keywords

PENTOSTATIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FOLLOW UP; HAIRY CELL LEUKEMIA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL;

EID: 0030862856     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.2273044.x     Document Type: Article

References (27)

1. Ambrosetti, A., Semenzato, G., Prior, M., Chilosi, M., Vinante, F., Vincenzi, C., Zanotti, R., Trentin, L., Portuese, A., Menestrina, F., Perona, G., Agostini, C., Todeschini, G. & Pizzolo, G. (1989) Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk. British Journal of Haematology, 73, 181-186.
2. Barak, V., Nisman, B., Dann, E.J., Kalickman, I., Ruchlemer, R., Bennett, M.A. & Polliack, A. (1994) Serum interleukin 1 beta levels as a marker in hairy cell leukemia: correlation with disease status and sIL-2R levels. Leukemia and Lymphoma, 14, (Suppl. 1), 33-39.
3. Catovsky, D. & Foa, R. (1990) The Lymphoid Leukaemias. Butterworth, London.
4. Catovsky, D., Matutes, E., Garcia Talavera, J., O'Connor, N.T.J., Johnson, S.A.N., Emmett, E., Corbett, L. & Swansbury, J. (1994) Long-term results with 2-deoxycoformycin in hairy cell leukemia. Leukemia and Lymphoma, 14, (Suppl. 1), 109-114.
5. Cordell, J.L., Falini, B., Erber, W.N., Ghosh, A.K., Abdulaziz, Z., MacDonald, S., Pulford, K.A.F., Stein, H. & Mason, D.Y. (1984) Immunoenzymatic labelling of monoclonal antibodies using immuno complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). Journal of Histochemistry and Cytochemistry, 32, 219-229.
6. Di Celle, P.F., Reato, G., Raspadori, D., Carbone, A., Rondelli, D., Lauria, F. & Foa, R. (1994) Molecular evaluation of clonal remission in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine. Leukemia and Lymphoma, 14, (Suppl. 1), 139-142.
7. Ellison, D.J., Sharpe, R.W., Robbins, H.A., Spinosa, J.C., Leopard, J.D., Saven, A. & Piro, L.D. (1994) Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia. Blood, 84, 4310-4315.
8. Falini, B., Pileri, S.A., Flenghi, L., Liberati, M., Stein, H., Gerli, R., Minelli, O., Martelli, M.F., Lauria, F. & Poggi, S. (1990) Selection of a panel of monoclonal antibodies for monitoring residual disease in peripheral blood and bone marrow of interferon-treated hairy cell leukemia patients. British Journal of Haematology, 76, 460-468.
9. Filleul, B., Delannoy, A., Ferrant, A., Zenebergh, A., Van Daele, S., Bosly, A., Doyen, C., Mineur, P., Glorieux, P., Driesschaert, P., Sokal, G., Martiat, P. & Michaux, J.L. (1994) A single course of 2-chlorodeoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission. Leukemia, 8, 1153-1156.
10. Foa, R., Tassinari, A., Fierro, M.T., Raspadori, D., Resegotti, L., Degani, G., Saglio, G., di Celle, P.F. & Lauria, F. (1990) Immunoglobulin DNA analysis as a marker of clonality in the follow-up of patients with hairy cell leukemia treated with alpha-interferon. Leukemia and Lymphoma, 2, 103-110.
11. Hakimian, D., Tallman, M.S., Killey, C. & Peterson, L.A. (1993) Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. Blood, 82, 1798-1802.
12. Matutes, E., Morilla, R., Owusu-Ankomah, K., Houliham, A., Meeus, P. & Catovsky, D. (1994) The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leukemia and Lymphoma, 14, (Suppl. 1), 57-61.
13. Mercieca, J., Puga, M., Matutes, E., Moskovic, E., Salim, S. & Catovsky, D. (1994) Incidence and significance of abdominal lymphadenopathy in hairy cell leukemia. Leukemia and Lymphoma, 14, (Suppl. 1), 79-84.
14. + T cells. Blood, 76, 959-964.
15. Pileri, S., Sabattini, E., Poggi, S., Merla, E., Raspadori, D., Benfenati, D., Rondelli, D., Benni, M., Ventura, M.A., Falini, B., Del Sol, G. & Lauria, F. (1994) Bone marrow biopsy in hairy cell leukemia (HCL) paitents: histological and immunohistological analysis of 46 cases treated with different therapies. Leukemia and Lymphoma, 14, (Suppl. 1), 67-71.
16. Piro, L., Carrera, C., Carson, D. & Beutler, E. (1990) Lasting remissions in hairy cell leukemia by a single infusion of 2-chlorodeoxy-adenosine. New England Journal of Medicine, 322, 1117-1221.
17. Posnett, D.N., Chiorazzi, N. & Kunkel, H.G. (1982) Monoclonal antibodies with specificity for hairy cell leukemia cells. Journal of Clinical Investigation, 70, 254-261.
18. Quesada, J.R., Reuben, J., Manning, J.T., Hersh, E.M. & Gutterman, J.U. (1984) Alpha interferon for induction of remission in hairy cell leukemia. New England Journal of Medicine, 310, 15-18.
19. Richards, J.M., Mick, R., Latta, J.M., Daly, K., Ratain, M.J., Vardiman, J.W. & Golomb, H.M. (1990) Serum soluble interleukin-2 receptor is associated with clinical and pathological disease status in hairy cell leukemia. Blood, 76, 1941-1945.
20. Robbins, B.A., Ellison, D.J., Spinosa, J.C., Carey, C.A., Lukes, R.J., Poppema, S., Saven, A. & Piro, L.D. (1993) Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood, 82, 1277-1287.
21. Schwarting, R., Stein, H. & Wang, C.Y. (1985) The monoclonal antibodies anti-S-HCL1 (Leu-14) and anti-S-HCL3 (Leu-M5) allow the diagnosis of hairy cell leukemia. Blood, 65, 974-983.
22. Tallman, M.S., Hakimian, D., Rademaker, A.W., Zanzig, C., Wollins, E., Rose, E. & Peterson, L.A. (1966) Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow up of the Northwestern University experience. Blood, 88, 1954-1959.
23. Thaler, J., Dietze, O., Faber, V., Greil, R., Gastl, G., Denz, H., Ho, A.D. & Huber, H. (1990) Monoclonal antibody B-ly-7: a sensitive marker for detection of minimal residual disease. Leukemia, 4, 170-176.
24. Thaler, J., Grunewald, K., Gattringer, C., Ho, A.D., Weyrer, K., Dietze, O., Stauder, R., Fluckinger, T., Lang, A. & Huber, H. (1993) Long-term follow-up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltration. British Journal of Haematology, 84, 75-82.
25. Visser, L., Shaw, A., Slupsky, J., Vos, H. & Poppema, S. (1989) Monoclonal antibodies reactive with hairy cell leukemia. Blood, 74, 320-325.
26. Wheaton, S., Tallman, M.S., Hakimian, D. & Peterson, L. (1996) Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine. Blood, 87, 1556-1560.
27. Worman, C.P., Catovsky, D., Bevan, P.C., Camba, L., Joyner, M., Green, P.J., Williams, H.J.H., Bottomley, J.M., Gordon-Smith, E.C. & Cawley, J.C. (1985) Interferon is effective in hairy cell leukaemia. British Journal of Haematology, 60, 759-763.